SULTAN, Abdulaziz Al, Ericka TELEG, MacKenzie HORN, Piyush OJHA, Linda MACHOVÁ, Sina MARZOUGHI, Tomoyuki OHARA, Ankur BANERJEE, Girish KULKARNI, Amy BOBYN, Anneliese NEWEDUK, Kennedy HORN, David RODRIGUEZ-LUNA, Mayank GOYAL, Bijoy K MENON a Andrew M DEMCHUK. Ongoing Leakage Revealed by Second Phase Spot Sign Volume Expansion in Multi-Phase Computed Tomography Angiography Strongly Predicts Intracranial Hemorrhage Growth. In INTERNATIONAL STROKE CONFERENCE 2020. 2020.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Ongoing Leakage Revealed by Second Phase Spot Sign Volume Expansion in Multi-Phase Computed Tomography Angiography Strongly Predicts Intracranial Hemorrhage Growth
Autoři SULTAN, Abdulaziz Al, Ericka TELEG, MacKenzie HORN, Piyush OJHA, Linda MACHOVÁ, Sina MARZOUGHI, Tomoyuki OHARA, Ankur BANERJEE, Girish KULKARNI, Amy BOBYN, Anneliese NEWEDUK, Kennedy HORN, David RODRIGUEZ-LUNA, Mayank GOYAL, Bijoy K MENON a Andrew M DEMCHUK.
Vydání INTERNATIONAL STROKE CONFERENCE 2020, 2020.
Další údaje
Typ výsledku Konferenční abstrakt
Utajení není předmětem státního či obchodního tajemství
WWW URL
Organizační jednotka Lékařská fakulta
Příznaky Mezinárodní význam
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 16. 9. 2021 12:42.
Anotace
Background: CTA spot sign is a predictor of intracerebral hemorrhage (ICH) expansion. This sign can fluctuate in appearance, volume, and timing. Multiphase CTA (mCTA) can identify spot sign through 3 time-resolved images. We sought to identify a novel predictor of follow up total hematoma expansion using mCTA. Methods: This cohort study included patients with ICH between 2012-2019. Quantomo software was used to measure total hematoma volume (ml) from baseline CT & follow-up CT/MRI blinded to spot sign in 3 mCTA phases. Spot sign expansion was calculated by subtracting 1st phase spot sign volume from 2nd phase spot sign volume measured in microliters. Results: 199 patients [63% male, mean age 69 years, median NIHSS 11, IQR 6-20] were included. Median baseline ICH volume was 16.1 ml (IQR 5-29.9 ml). Amongst all three mCTA phases, spot sign was best detected on the 2nd phase (23% vs 17.5% 1st phase vs 22% 3rd phase). In multivariable regression, spot sign expansion was significantly associated with follow up total hematoma expansion (OR: 1.03 per microliter of spot sign expansion, p=0.01). Figure 1 shows the predicted total hematoma expansion by spot sign expansion. mCTA spot sign had a higher sensitivity for predicting total hematoma volume expansion than single-phase CTA (reported in meta-analysis of 14 studies), 86% vs 53%, respectively, while both having similar specificity, 87% vs 88%, respectively. Conclusion: Spot sign expansion on mCTA is a novel predictor of total hematoma expansion and could be used to select patients for immediate therapeutic intervention in future clinical trials. Using mCTA improves sensitivity while preserving specificity over single-phase CTA.
VytisknoutZobrazeno: 26. 7. 2024 00:27